Health Innovation Spotlight: Neonatal Jaundice

News > News > Health Innovation Spotlights > Health Innovation Spotlight: Neonatal Jaundice

Shining a light on babies.

Innovations in Neonatal Jaundice

Neonatal Jaundice is a common and usually harmless condition in newborn babies that causes yellowing of the skin and the whites of the eyes. In mild cases this usually goes away after 1 or 2 weeks. But sometimes a baby needs more help in the form of a medical treatment called phototherapy or light therapy.


The team at Neolight, a medical device company in Scottsdale Arizona, created Skylife to help babies with jaundice. Unlike larger systems that can only be used in a clinical or hospital setting and often result in parents and their baby being separated during the precious early days of life, Skylife is small, portable, and can even be used in a home setting allowing Parents and Baby the opportunity to stay together and bond.   

Learn more about Neolight 

Health Innovations for Babies & Children

When it comes to treatments and cures, babies and children need and deserve a special innovation focus.

One example is INC – the International Neonate Consortium led by the Critical Path Institute in Tucson. Launched on May 19, 2015, INC is C-Path’s ninth consortium – a global collaboration formed to forge a predictable regulatory path for evaluating the safety and effectiveness of therapies for neonates. “By uniting stakeholders from research institutions, drug developers, regulatory agencies, patient advocacy and other organizations,” said Janet Woodcock, Director of the U.S. Food and Drug Administration’s Center for Drug Evaluation and Research (FDA/CDER), “INC can develop practical tools that can be incorporated into clinical trials for neonates, which will then lead to more successful, efficient trials and provide this population with better treatments.”

About the AZAdvances Public Information Campaign

The AZAdvances Public Information Campaign  shares stories of health innovations that are being discovered, developed, and delivered in Arizona.  The  initiative is led by AZBio in partnership with the Opportunity Through Entrepreneurship Foundation (OTEF). Working together, AZBio and OTEF are building  AZAdvances to help more Arizona healthcare innovations move forward faster.